Skip to main content
SpringerLink
Log in

Role of apoptosis in ventricular remodeling

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Cell loss is a common feature in the failing heart, and this contributes to the relentless progression seen in patients with heart failure. Apoptosis is one of the most common causes of cell loss in animals and humans with heart failure. There is increasing evidence that apoptosis, even while occurring in a low-grade manner, can mediate heart failure. Moreover, inhibiting apoptosis successfully prevents or attenuates heart failure in several animal models. More importantly, apoptosis is one of the few mechanisms that can be easily modulated using pharmacologic or gene therapy approaches. Animal data, obtained in the past few years, have proven the feasibility and success of this approach toward altering the natural history of heart failure. Human studies are pending, but a number of issues such as the type of inhibitor and its optimum timing/dose will need to be resolved before this becomes a reality. Nevertheless, these data will accrue over time, and antiapoptotic therapy is likely to emerge as an important form of heart failure therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. American Heart Association: Heart Disease and Stroke Statistics-2003 Update. Dallas: American Heart Association; 2002.

    Google Scholar 

  2. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22:6A-13A.

    Article  PubMed  CAS  Google Scholar 

  3. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161–1172.

    PubMed  CAS  Google Scholar 

  4. White HD, Norris RM, Brown MA, et al.: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987, 76:44–51.

    PubMed  CAS  Google Scholar 

  5. Rousseau MF, Konstam MA, Benedict CR, et al.: Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol 1994, 73:488–493.

    Article  PubMed  CAS  Google Scholar 

  6. Beltrami CA, Finato N, Rocco M, et al.: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995, 27:291–305.

    Article  PubMed  CAS  Google Scholar 

  7. Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003, 92:139–150. This paper, with a number of others by this group, demonstrates the regenerative potential of cardiac myocytes, cells which were once considered terminally differentiated cells. This also suggests that a balance between cell loss and cell regeneration might determine the fate of cardiac mass in the failing heart.

    Article  PubMed  CAS  Google Scholar 

  8. MajnoG, Joris I: Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995, 146:3–15.

    PubMed  CAS  Google Scholar 

  9. Chandrashekhar Y, Narula JN: Cell death, cell survival, and the failing heart. Circ Res 2003, 92:710–714. This paper, with the study by Takemura and Fujiwara [12], provides a brief overview of issues associated with life and death in cells from the failing heart.

    Article  PubMed  CAS  Google Scholar 

  10. Kostin S, Pool L, Elsässer A, Hein S, et al.: Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003, 92:715–724.

    Article  PubMed  CAS  Google Scholar 

  11. Mani K, Kitsis RN: Myocyte apoptosis: programming ventricular remodeling. J Am Coll Cardiol 2003, 41:761–764.

    Article  PubMed  Google Scholar 

  12. Takemura G, Fujiwara H: Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther 2004, 104:1–16.

    Article  PubMed  CAS  Google Scholar 

  13. Cheng W, Kajstura J, Nitahara JA, et al.: Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996, 226:316–327.

    Article  PubMed  CAS  Google Scholar 

  14. Narula J, Haider N, Virmani R, et al.: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996, 335:1182–1189. This was the first paper to demonstrate the occurrence of myocyte apoptosis in the failing human heart. It is accompanied by an editorial outlining the potential role of apoptosis in cell loss in heart failure. Many of the implied predictions in these two papers have come to be true.

    Article  PubMed  CAS  Google Scholar 

  15. Bialik S, Geenen DL, Ssson IE, et al.: The Caspase family cysteine proteases mediate cardiac myocyte apoptosis during myocardial infarction. Circulation 1997, 96:I-552.

    Google Scholar 

  16. Beltrami CA, Finato N, Rocco M, et al.: Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994, 89:151–163.

    PubMed  CAS  Google Scholar 

  17. Bing OH: Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 1994, 26:943–948.

    Article  PubMed  CAS  Google Scholar 

  18. Kang PM, Izumo S: Apoptosis and heart failure: a critical review of the literature. Circ Res 2000, 86:1107–1113. This is a very good overview of the apoptosis in heart failure. It is somewhat dated now but contains a significant amount of background data.

    PubMed  CAS  Google Scholar 

  19. Kanoh M, Takemura G, Misao J, et al.: Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 1999, 99:2757–2764. This paper challenges the use of the traditional method (TUNEL) of detecting apoptosis and makes the case for more rigorous methodology in identifying apoptosis.

    PubMed  CAS  Google Scholar 

  20. Li Y, Takemura G, Kosai K, et al.: Critical roles for the Fas/ Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 2004, 95:627–636.

    Article  PubMed  CAS  Google Scholar 

  21. Garg S, Narula J, Chandrashekhar Y: Apoptosis and heart failure: clinical relevance and therapeutic target. J Mol Cell Cardiol 2005, In Press.

  22. Communal C, Sumandea M, de Tombe P, et al.: Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 2002, 99:6252–6256.

    Article  PubMed  CAS  Google Scholar 

  23. LaugwitzKL, Moretti A, Weig HJ, et al.: Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 2001, 12:1251–1263.

    Article  Google Scholar 

  24. Moretti A, Weig HJ, Ott T, et al.: Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci U S A 2002, 99:11860–11865.

    Article  PubMed  CAS  Google Scholar 

  25. Chandrashekhar Y, Sen S, Anway R, et al.: Long term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects LV function and attenuates remodeling in rats with a MI. J Am Coll Cardiol 2004, 43:295–301.

    Article  PubMed  CAS  Google Scholar 

  26. Narula J, Arbustini E, Chandrashekhar Y, Schwaiger M: Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 2001, 19:113–126.

    Article  PubMed  CAS  Google Scholar 

  27. Wencker D, Chandra M, Nguyen K, et al.: A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003, 111:1497–1504. This is one of the seminal papers that "nailed" the role of apoptosis in the genesis of heart failure. It contains quantitative data suggesting that even a low level of chronic apoptosis is sufficient to induce severe heart failure. This paper is accompanied by an excellent editorial about the role of cell death and regeneration in the failing heart.

    Article  PubMed  CAS  Google Scholar 

  28. Hayakawa Y, Chandra M, Miao W, et al.: Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003, 108:3036–3041.

    Article  PubMed  CAS  Google Scholar 

  29. Yamamoto S, Yang G, Zablocki D, et al.: Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest 2003, 111:1463–1474.

    Article  PubMed  CAS  Google Scholar 

  30. Condorelli G, Roncarati R, Ross J Jr, et al.: Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci USA 2001, 98:9977–9982.

    Article  PubMed  CAS  Google Scholar 

  31. Yamaguchi O, Higuchi Y, Hirotani S, et al.: Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 2003, 100:15883–15888.

    Article  PubMed  CAS  Google Scholar 

  32. Frantz S, Ducharme A, Sawyer D, et al.: Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol 2003, 35:685–694.

    Article  PubMed  CAS  Google Scholar 

  33. Engel D, Peshock R, Armstong RC, et al.: Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 2004, 287:H1303-H1311.

    Article  PubMed  CAS  Google Scholar 

  34. Moe GW, Marin-Garcia J, Konig A, et al.: In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. AmJ Physiol Heart Circ Physiol 2004, 287:H1813-H1820.

    Article  CAS  Google Scholar 

  35. Okamura T, Miura T, Takemura G, et al.: Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 2000, 45:642–650.

    Article  PubMed  CAS  Google Scholar 

  36. Holly TA, Drincic A, Byun Y, et al.: Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999, 31:1709–1715.

    Article  PubMed  CAS  Google Scholar 

  37. Neviere R, Fauvel H, Chopin C, et al.: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 2001, 163:218–225.

    PubMed  CAS  Google Scholar 

  38. Hayakawa K, Takemura G, Kanoh M, et al.: Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 2003, 108:104–109. This paper, along with the study by Chandrashekhar et al. [25], was the first to demonstrate that pharmacologic inhibition of caspase activity reduces apoptosis and attenuates ventricular remodeling. This paper stresses the importance of inhibiting granulation tissue apoptosis, whereas others, including the study by Chandrashekhar et al. [25], show the importance of inhibiting cardiomyocyte apoptosis.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology IIIc, University of Minnesota; VA Medical Center, 1 Veterans Drive, 55417, Minneapolis, MN, USA

    Y. Chandrashekhar MD, DM

Authors
  1. Y. Chandrashekhar MD, DM
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chandrashekhar, Y. Role of apoptosis in ventricular remodeling. Curr Heart Fail Rep 2, 18–22 (2005). https://doi.org/10.1007/s11897-005-0003-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-005-0003-5

Keywords

Search

Navigation